| DNA nanostructures at the interface with biology KE Bujold, A Lacroix, HF Sleiman Chem 4 (3), 495-521, 2018 | 183 | 2018 |
| Uptake and Fate of Fluorescently Labeled DNA Nanostructures in Cellular Environments: A Cautionary Tale A Lacroix, E Vengut-Climent, D de Rochambeau, HF Sleiman ACS Central Science, 2019 | 148 | 2019 |
| Development of DNA nanostructures for high-affinity binding to human serum albumin A Lacroix, TGW Edwardson, MA Hancock, MD Dore, HF Sleiman Journal of the American Chemical Society 139 (21), 7355-7362, 2017 | 143 | 2017 |
| DNA Nanostructures: Current Challenges and Opportunities for Cellular Delivery A Lacroix, HF Sleiman ACS Nano, 2021 | 99 | 2021 |
| Premature activation of Cdk1 leads to mitotic events in S phase and embryonic lethality R Szmyd, J Niska-Blakie, MK Diril, P Renck Nunes, K Tzelepis, A Lacroix, ... Oncogene 38 (7), 998-1018, 2019 | 61 | 2019 |
| Innovative developments and emerging technologies in RNA therapeutics F Halloy, A Biscans, KE Bujold, A Debacker, AC Hill, A Lacroix, O Luige, ... RNA Biology 19 (1), 2022 | 25 | 2022 |
| Detailed cellular assessment of albumin-bound oligonucleotides: Increased stability and lower non-specific cell uptake A Lacroix, HH Fakih, HF Sleiman Journal of Controlled Release 324, 34-46, 2020 | 19 | 2020 |
| Templated synthesis of spherical RNA nanoparticles with gene silencing activity MD Dore, JJ Fakhoury, A Lacroix, HF Sleiman Chemical communications 54 (80), 11296-11299, 2018 | 11 | 2018 |
| Correction: Premature activation of Cdk1 leads to mitotic events in S phase and embryonic lethality R Szmyd, J Niska-Blakie, MK Diril, PR Nunes, K Tzelepis, A Lacroix, ... Oncogene 39 (9), 2030, 2020 | 1 | 2020 |
| RNA Versus Protein, How Structure Influences Targeting, a New Challenge for Drug Discovery A Bonetti, A Lacroix, E Walsh, A Ghidini RNA Structure and Function, 119-144, 2023 | | 2023 |
| 17th Annual Meeting of the Oligonucleotide Therapeutics Society: A Tribute to Bob Letsinger, Progress in N = 1 Treatments, and Successful First In-Humans CRISPR Trials RAM Buijsen, A Lacroix, J Ocaba, D O'Reilly, L Abdullahu, EM McConnell, ... Nucleic Acid Therapeutics 32 (1), 2022 | | 2022 |
| DNA structures at the interface with biology: study and optimization of their outcomes in physiological conditions A Lacroix McGill University, 2020 | | 2020 |
